The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Open accessAbstract
Human MHC class I-related molecules, MICA and MICB, are stress-induced antigens that are recognized by a subset of γδ T cells expressing the variable region V δ 1. This functional association has been found to be limited to intestinal epithelium, where these T cells are prevalent and where MICA and, presumably, MICB are mainly expressed. However, increased frequencies of V δ 1 γδ T cells have been observed in various epithelial tumors; moreover, MICA/B are expressed on diverse cultured epithelial tumor cells. With freshly isolated tumor specimens, expression of MICA/B was documented in many, but not all, carcinomas of the lung, breast, kidney, ovary, prostate, and colon. In tumors that were positive for MICA/B, the frequencies of V δ 1 γδ T cells were significantly higher than in those that were negative. V δ 1 γδ T cell lines and clones derived from different tumors recognized MICA/B on autologous and heterologous tumor cells. In accord with previous evidence, no constraints were observed in these interactions, such as those imposed by specific peptide ligands. Thus, MICA/B are tumor-associated antigens that can be recognized, in an apparently unconditional manner, by a subset of tumor-infiltrating γδ T cells. These results raise the possibility that an induced expression of MICA/B, by conditions that may be related to tumor homeostasis and growth, could play a role in immune responses against tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
Groh, V., Steinle, A., Bauer, S., & Spies, T. (1998) · Science · doi:10.1126/science.279.5357.1737 · Cited by 1,142
Self-citationGroh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Self-citationMECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008
Peptides Naturally Presented by MHC Class I Molecules
Rammensee, H. G., Falk, K., & Rötzschke, O. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001241 · Cited by 799
A second lineage of mammalian major histocompatibility complex class I genes.
Bahram, S., Bresnahan, M., Geraghty, D. E., & Spies, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6259 · Cited by 784
Self-citationUse of a Monoclonal Antibody (W6/32) in Structural Studies of HLA-A,B,C Antigens
Parham, P., Barnstable, C. J., & Bodmer, W. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.1.342 · Cited by 673
Van den Eynde, B. J., & van der Bruggen, P. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80050-7 · Cited by 623
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire.
Parker, C. M., Groh, V, Band, H., Porcelli, S. A., Morita, C., Fabbi, M., Glass, D., Strominger, J. L., & Brenner, M. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1597 · Cited by 521
Self-citationCDR3 length in antigen-specific immune receptors.
Rock, E. P., Sibbald, P. R., Davis, M. M., & Chien, Y. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.323 · Cited by 510
Ferrone, S., & Marincola, F. M. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80033-6 · Cited by 474
Cited by
Items 101–110 of 110
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Lazarova, M., & Steinle, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02689 · Cited by 149
Effects of milk fermented by Lactobacillus helveticusR389 on a murine breast cancer model
de Moreno de LeBlanc, A., Matar, C., LeBlanc, N., & Perdigón, G. (2005) · Breast Cancer Research · doi:10.1186/bcr1032 · Cited by 119
“Tumour infiltrating lymphocytes from ovarian tumours released this cytokine upon challenge with MICA-positive tumour cells [25].”
BackgroundHoltmeier, W., Pfänder, M., Hennemann, A., Caspary, W. F., Zollner, T. M., & Kaufmann, R. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01250.x · Cited by 101
Human γδ T-Cell Control of Mucosal Immunity and Inflammation
McCarthy, N. E., & Eberl, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00985 · Cited by 96
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Shankar, K., Capitini, C. M., & Saha, K. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01741-4 · Cited by 85
Pregnancy and gamma/delta T cells: Taking on the hard questions
Mincheva-Nilsson, L. (2003) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-1-120 · Cited by 79
Tokuyama, M., Lorin, C., Delebecque, F., Jung, H., Raulet, D. H., & Coscoy, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002265 · Cited by 51
Bukowski, J. F., & Percival, S. S. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.00013.x · Cited by 45
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein
Torres, N., Regge, M. V., Secchiari, F., Friedrich, A. D., Spallanzani, R. G., Raffo Iraolagoitia, X. L., Núñez, S. Y., Sierra, J. M., Ziblat, A., Santilli, M. C., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000233 · Cited by 29
Immunobiology of primary sclerosing cholangitis
Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K. (2025) · Hepatology · doi:10.1097/hep.0000000000001080 · Cited by 20
Metadata
- Authors
- Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-06-08
- Volume
- 96
- Issue
- 12
- Pages
- 6879-6884
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1993786192
- Cited by
- 1,028
- References
- 22
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.